- Home
- AGMH vs SBFM Comparison
AGMH vs SBFM Comparison
Compare AGMH & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMH | SBFM |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.2M |
| IPO Year | 2017 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AGMH | SBFM |
|---|---|---|
| Price | $0.51 | $2.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.6M | ★ 10.3M |
| Earning Date | 11-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,305,891.00 |
| Revenue This Year | N/A | $1.23 |
| Revenue Next Year | N/A | $22.44 |
| P/E Ratio | $0.07 | ★ N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $0.41 | $0.13 |
| 52 Week High | $4.29 | $18.50 |
Technical Indicators
Market Signals| Indicator | AGMH | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 77.69 |
| Support Level | $0.48 | $1.06 |
| Resistance Level | $1.42 | $3.05 |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | 0.01 | 0.36 |
| Stochastic Oscillator | 61.75 | 85.86 |
Price Performance
Historical ComparisonAbout AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is a technology company engaged in technology hardware research and development, manufacturing, assembly, and sales. Its core business segments include research and development of blockchain-oriented ASIC chips, production of high-end crypto miners for Bitcoin and other cryptocurrencies, and Fintech software services. The Company mainly derives revenue from the sales of cryptocurrency mining machines and standardized computing equipment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.